P3 Health Partners reported earnings of $ 0.07 per PIII share on Nov 9, 2026, falling short of analysts' expectations by
| Report Date | Nov 9, 2026 |
|---|---|
| Forecasted EPS | -$ 3.96 |
| Earnings Per Share (Surprise) | $ 0.07 (+$ 4.03) |
| Last Year's EPS | -$ 11.30 |
| EPS YoY Change |
Out of the last 26 earnings reporting periods, P3 Health Partners beat analysts’ expectations 7 times and fell short of expectations 11 time(s). P3 Health Partners reported earnings per share of $ 0.07 in the last report surpassing an estimated EPS of -$ 3.96 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 9, 2026 | -$ 3.96 | $ 0.07 | -$ 9.67 | |
| Aug 10, 2026 | -$ 1.89 | -$ 0.63 | -$ 6.23 | |
| May 14, 2026 | -$ 4.85 | $ 0.32 | -$ 6.28 | |
| Mar 26, 2026 | -$ 8.06 | -$ 23.02 | -$ 16.00 | |
| Nov 14, 2025 | -$ 5.29 | -$ 9.67 | -$ 15.50 | |
| Aug 14, 2025 | -$ 3.29 | -$ 6.23 | -$ 7.50 | |
| May 15, 2025 | -$ 5.00 | -$ 6.28 | -$ 8.00 | |
| Mar 27, 2025 | -$ 8.50 | -$ 16.00 | -$ 11.00 | |
| Nov 12, 2024 | -$ 1.50 | -$ 15.50 | -$ 6.00 | |
| Aug 7, 2024 | -$ 4.00 | -$ 7.50 | -$ 4.50 | |
| May 8, 2024 | -$ 9.50 | -$ 8.00 | -$ 11.00 | |
| Mar 28, 2024 | -$ 9.50 | -$ 11.00 | -$ 1,124.55 | |
| Nov 8, 2023 | -$ 11.50 | -$ 6.00 | -$ 0.27 | |
| Aug 7, 2023 | -$ 12.00 | -$ 4.50 | -$ 12.72 | |
| May 10, 2023 | -$ 4.50 | -$ 11.00 | -$ 84.55 | |
| Mar 31, 2023 | -$ 0.01 | -$ 1,124.55 | -$ 39.71 | |
| Nov 14, 2022 | -$ 0.46 | -$ 0.27 | -$ 36.50 | |
| Apr 25, 2022 | -$ 0.91 | -$ 12.72 | -$ 31.18 | |
| Dec 31, 2021 | - | -$ 84.55 | -$ 4.65 | |
| Dec 9, 2021 | - | -$ 39.71 | -$ 21.13 |
P3 Health Partners’s stock was trading at $ 4.00 on Nov 8, 2026 a day before the last earnings report was released.Following the release of the earnings report, PIII’s price decreased to $ 3.38 on Nov 10, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 9, 2026 | $ 0.07 | $ 4.00 | $ 3.38 | |
| Aug 10, 2026 | -$ 0.63 | $ 11.58 | $ 12.37 | |
| May 14, 2026 | $ 0.32 | $ 3.57 | $ 11.29 | |
| Mar 26, 2026 | -$ 23.02 | $ 3.11 | $ 2.94 | |
| Nov 14, 2025 | -$ 9.67 | $ 7.00 | $ 5.98 | |
| Aug 14, 2025 | -$ 6.23 | $ 7.10 | $ 6.78 | |
| May 15, 2025 | -$ 6.28 | $ 8.18 | $ 7.99 | |
| Mar 27, 2025 | -$ 16.00 | $ 8.90 | $ 8.65 | |
| Nov 12, 2024 | -$ 15.50 | $ 19.80 | $ 12.50 | |
| Aug 7, 2024 | -$ 7.50 | $ 30.30 | $ 29.55 | |
| May 8, 2024 | -$ 8.00 | $ 35.70 | $ 36.60 | |
| Mar 28, 2024 | -$ 11.00 | $ 51.00 | $ 44.25 | |
| Nov 8, 2023 | -$ 6.00 | $ 71.00 | $ 69.50 | |
| Aug 7, 2023 | -$ 4.50 | $ 111.00 | $ 112.00 | |
| May 10, 2023 | -$ 11.00 | $ 102.00 | $ 115.50 | |
| Mar 31, 2023 | -$ 1,124.55 | $ 55.00 | $ 51.75 | |
| Nov 14, 2022 | -$ 0.27 | $ 271.50 | $ 239.50 | |
| Apr 25, 2022 | -$ 12.72 | $ 324.50 | $ 343.00 | |
| Dec 31, 2021 | -$ 84.55 | $ 383.50 | $ 324.50 | |
| Dec 9, 2021 | -$ 39.71 | $ 477.00 | $ 572.00 |
P3 Health Partners released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
P3 Health Partners beat analysts’ expectations during the last earnings period by
